Among these, IFN-γ production by CpG-proBs and their progeny proved to be critical for alleviating GVHD symptoms, particularly skin fibrosis, as previously shown in experimental models of autoimmune diseases, such as T1D (15) and EAE (16). This evidence concerns the gene IFNG and graft versus host disease.